Anand Rathi Share and Stock Brokers Limited has completed the allotment of 3,01,050 equity shares under its Employee Stock Option Plan 2023, following approval from the company's Nomination & Remuneration Committee. The decision was made during a committee meeting held on April 14, 2026, demonstrating the company's commitment to employee participation in its growth.

ESOP Allotment Details

The allotment process was formally approved by the Nomination & Remuneration Committee of the Board of Directors during their meeting on April 14, 2026. The committee session was conducted efficiently, commencing at 10:00 a.m. and concluding at 10:30 a.m.

Regulatory Compliance and Share Rights

The allotment was conducted pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The shares were allocated specifically to those option grantees who had exercised their options under the company's Employee Stock Option Plan 2023.

The newly allotted equity shares will rank pari passu with the existing equity shares of the company, ensuring that the holders receive equal rights and privileges as existing shareholders. This standard practice maintains equity among all shareholders regardless of when their shares were issued.

Corporate Communication

The company has fulfilled its disclosure obligations by informing both major stock exchanges about this development. The information has been communicated to BSE Limited and the National Stock Exchange of India Ltd., ensuring transparency in corporate actions. Additionally, the company has made this information available on its official website at anandrathi.com/investors for stakeholder access.

CARE Ratings Limited has announced comprehensive credit rating upgrades for Anand Rathi Share and Stock Brokers Limited (ARSSBL), reflecting the company's strengthened financial position following a substantial equity infusion. The rating agency upgraded all debt instruments and bank facilities, citing improved financial flexibility and enhanced leverage metrics.

Rating Upgrades Across All Instruments

The credit rating upgrades span across ARSSBL's entire portfolio of debt instruments and banking facilities:

The upgrades were communicated through CARE Ratings' letter dated April 08, 2026, and subsequently disclosed by ARSSBL to stock exchanges under Regulation 30 of SEBI listing requirements.

Key Drivers Behind Rating Enhancement

The rating upgrade primarily reflects the significant equity infusion of ₹745 crore raised through ARSSBL's initial public offering in September 2025. This capital injection has substantially improved the company's financial flexibility and is expected to support growth in the margin trading facility (MTF) and distribution segments while improving leverage metrics over the medium term.

ARSSBL's tangible net worth increased dramatically to ₹1,335 crore as on December 31, 2025, from ₹495 crore as on March 31, 2025. Consequently, overall gearing moderated significantly from 2.59x in FY25 to 0.90x in 9MFY26, while fund-based gearing improved from 1.83x to 0.59x during the same period.

Financial Performance and Business Diversification

The company demonstrated strong financial performance in FY25, with total income growing 23.73% to ₹845 crore, driven by higher interest income and brokerage revenue. Profit after tax stood at ₹104 crore, translating to a PAT margin of 12.29%, reflecting an improvement of 78 basis points year-on-year.

ARSSBL has successfully diversified its revenue profile, reducing dependence on volatile broking income. While brokerage contributed approximately 80% of total income in FY17, its share declined to 52.39% in FY25 and 44.68% in 9MFY26. The balance is now driven by interest income, primarily from MTF operations, and distribution income.

Rating Strengths and Constraints

CARE Ratings highlighted several key strengths supporting the upgraded ratings:

• Experienced management team led by co-founder and Managing Director Pradeep Gupta
• Established presence in the broking industry with over three decades of experience
• Strategic importance within the diversified Anand Rathi Group ecosystem
• Stable earnings profile with diversified income streams
• Strong liquidity position with overall liquidity of ₹3,197 crore as on December 31, 2025

However, the ratings remain constrained by modest scale of broking operations relative to larger industry peers, inherent risks associated with capital market-linked businesses, competitive intensity in the core broking segment, and the evolving regulatory landscape affecting the sector.

Market Position and Growth Outlook

ARSSBL maintains a market share of 0.25% across both cash and derivatives segments in FY25, with relatively higher presence in the cash segment at 0.88%. The company's MTF book has emerged as a key growth driver, scaling from ₹305 crore as on March 31, 2022, to ₹1,232 crore as on December 31, 2025.

The asset under distribution (AUD) has grown from ₹2,772 crore as on March 31, 2022, to ₹8,369 crore as on December 31, 2025, with mutual funds comprising the largest component. CARE Ratings has assigned a stable outlook, expecting ARSSBL to continue demonstrating stable business profile with timely support from the parent company given its strategic importance and shared brand name.